UKGrowth Network

UK company record

Purespring Therapeutics

Gene therapy (kidney disease)

CandidateCore UK
Open interactive recordCompanies House profile

Snapshot

UK location
London · London
Sector
Biotech & techbio
Latest recorded round
Series B
Latest recorded amount
£80M / $105M
Date
2024-10-01

Legal-identity layer

Candidate identity.

Selected legal name
PURESPRING THERAPEUTICS LIMITED
Company number
12543677
Companies House status
active
Incorporated
2020-04-01

Investors

Current directors and active controllers

  • AHMAD, HaseebCurrent director
  • BHAMAN, MainaCurrent director
  • BOORSMA, Marco, DrCurrent director
  • FRANCIS, Richard DavidCurrent director
  • HALLEN, Sonia, DrCurrent director
  • HOLLOWOOD, Christopher John, DrCurrent director
  • Syncona LimitedActive controller
  • TSAI, John, DrCurrent director
  • FRANKEN, Arthur Lodewijkdirector
  • HANAK, Juliandirector
  • HOLLOWOOD, Christopher John, Drdirector
  • KYRIAKIDES, Michael, Mr.director
  • SALEEM-UDDIN, Moin Ahsondirector
  • SCHMIDT, Dominic, Drdirector
  • WILSON, Andrew Daviddirector

Funding rows

Sources